JP2005520864A5 - - Google Patents

Download PDF

Info

Publication number
JP2005520864A5
JP2005520864A5 JP2003578384A JP2003578384A JP2005520864A5 JP 2005520864 A5 JP2005520864 A5 JP 2005520864A5 JP 2003578384 A JP2003578384 A JP 2003578384A JP 2003578384 A JP2003578384 A JP 2003578384A JP 2005520864 A5 JP2005520864 A5 JP 2005520864A5
Authority
JP
Japan
Prior art keywords
group
substituted
lower alkyl
independently
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003578384A
Other languages
English (en)
Japanese (ja)
Other versions
JP4465193B2 (ja
JP2005520864A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/008449 external-priority patent/WO2003080630A2/en
Publication of JP2005520864A publication Critical patent/JP2005520864A/ja
Publication of JP2005520864A5 publication Critical patent/JP2005520864A5/ja
Application granted granted Critical
Publication of JP4465193B2 publication Critical patent/JP4465193B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003578384A 2002-03-19 2003-03-19 リン酸塩輸送インヒビター Expired - Fee Related JP4465193B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36594002P 2002-03-19 2002-03-19
PCT/US2003/008449 WO2003080630A2 (en) 2002-03-19 2003-03-19 Phosphate transport inhibitors

Publications (3)

Publication Number Publication Date
JP2005520864A JP2005520864A (ja) 2005-07-14
JP2005520864A5 true JP2005520864A5 (OSRAM) 2006-05-18
JP4465193B2 JP4465193B2 (ja) 2010-05-19

Family

ID=28454730

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003578384A Expired - Fee Related JP4465193B2 (ja) 2002-03-19 2003-03-19 リン酸塩輸送インヒビター

Country Status (7)

Country Link
US (2) US7109184B2 (OSRAM)
EP (1) EP1485391B1 (OSRAM)
JP (1) JP4465193B2 (OSRAM)
AT (1) ATE337326T1 (OSRAM)
AU (1) AU2003218270A1 (OSRAM)
DE (1) DE60307799T2 (OSRAM)
WO (1) WO2003080630A2 (OSRAM)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
AU2003218270A1 (en) 2002-03-19 2003-10-08 Genzyme Corporation Phosphate transport inhibitors
US7985418B2 (en) * 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
KR101547925B1 (ko) * 2005-09-15 2015-08-27 젠자임 코포레이션 아민 중합체에 대한 샤셋 제형
AU2012205214B2 (en) * 2005-09-15 2015-05-21 Genzyme Corporation Formulation for Amine Polymers
WO2009029829A1 (en) * 2007-08-29 2009-03-05 Sorbent Therapeutics, Inc. Polymeric compositions with enhanced saline holding capacity and their method of preparation and use
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
NO2384318T3 (OSRAM) 2008-12-31 2018-04-14
CA2749397A1 (en) * 2009-01-22 2010-08-05 Usv Limited Pharmaceutical compositions comprising phosphate-binding polymer
JP5783910B2 (ja) 2009-01-26 2015-09-24 シトクロマ インコーポレイテッド 小分子を用いるリン酸管理
EP2542560B8 (en) * 2010-03-05 2015-12-30 Duophos Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport
MX366293B (es) 2012-08-21 2019-07-04 Ardelyx Inc Compuestos y metodos para inhibir al antipuerto mediado por nhe en el tratamiento de trastornos asociados con la retencion de fluidos o la sobrecarga de sal y trastornos del tracto gastrointestinal.
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
EP3552630A1 (en) 2013-04-12 2019-10-16 Ardelyx, Inc. Nhe3-binding compounds for inhibiting phosphate transport
BR112019013963A2 (pt) 2017-01-09 2020-04-28 Ardelyx Inc inibidores de antiporte mediado por nhe
US11242337B2 (en) 2017-01-09 2022-02-08 Ardelyx, Inc. Compounds useful for treating gastrointestinal tract disorders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3632634A (en) * 1968-08-16 1972-01-04 Ludwig Maier Phosphorus compounds having the skeleton structure
DE1945146A1 (de) * 1968-09-06 1970-03-12 Monsanto Co Verfahren zur Herstellung von alpha.omega-Bis-(O.O'-diorganophosphonylmethyl-O-organophosphinyl-alkanen
US4806532A (en) 1985-10-08 1989-02-21 Mayo Foundation For Medical Education And Research Inhibition of epithelial phosphate transport
IL86951A (en) 1987-07-06 1996-07-23 Procter & Gamble Pharma Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
CA2007641A1 (en) 1989-02-01 1990-08-01 Donald S. Karanewsky Combination of squalene synthetase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination
CA2016467A1 (en) 1989-06-05 1990-12-05 Martin Eisman Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor
EP0563730A3 (en) * 1992-03-28 1994-07-27 Hoechst Ag Alkenylaminoalkylene phosphonic acid esters and process for the preparation of copolymers comprising alkenylaminoalkylene phosphonates and ethylenic unsaturated compounds
US5278153A (en) * 1992-05-18 1994-01-11 E. R. Squibb & Sons, Inc. Aryl and heteroaryl (phosphinylmethyl)phosphonate squalene synthetase inhibitors and method
US5719303A (en) 1993-03-08 1998-02-17 Eisai Co., Ltd. Phosphonic acid derivatives
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5496545A (en) 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5508342A (en) * 1994-02-01 1996-04-16 The United States Of America As Represented By The Secretary Of Commerce Polymeric amorphous calcium phosphate compositions
US5618851A (en) * 1995-02-06 1997-04-08 Arch Development Corp. Grafted methylenediphosphonate ion exchange resins
AU2003218270A1 (en) 2002-03-19 2003-10-08 Genzyme Corporation Phosphate transport inhibitors

Similar Documents

Publication Publication Date Title
JP2005520864A5 (OSRAM)
RU2008152087A (ru) Макроциклические оксимильные ингибиторы протеазы гепатита
JP2004516314A5 (OSRAM)
JP2011530500A5 (OSRAM)
JP2007536393A5 (OSRAM)
JP2005504789A5 (OSRAM)
JP2012512891A5 (OSRAM)
JP2008525416A5 (OSRAM)
JP2007502845A5 (OSRAM)
JP2008523069A5 (OSRAM)
JP2008505117A5 (OSRAM)
JP2013503905A5 (OSRAM)
JP2008533191A5 (OSRAM)
JP2015501292A5 (OSRAM)
JP2009535307A5 (OSRAM)
RU2003122190A (ru) Производные тетрагидропиридина, их получение и применение в качестве ингибиторов клеточной пролиферации
EP1826196A3 (en) Vinyl ether compounds
JP2010513498A5 (OSRAM)
JP2008536833A5 (OSRAM)
TW200600983A (en) Rinse solution for lithography
JP2006503143A5 (OSRAM)
JP2010535706A5 (OSRAM)
RU2019113149A (ru) Низкомолекулярные активаторы амфк
JP2021504302A5 (OSRAM)
JP2011526896A5 (OSRAM)